Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide. (Q39247530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sandra Coral

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hugues Nicolay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Riccardo Danielli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Elisabetta Fratta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Alessia Covre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Giulia Parisi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Francesca Colizzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Pietro Taverna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Luca Sigalotti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

9 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

605-614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23138873%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-012-1365-7

17 February 2020

exact match

0 references

cites work

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Induction of MAGE-3 expression in lung and esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Molecular, cellular and animal pharmacology of 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

MethPrimer: designing primers for methylation PCRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Cancer/testis (CT) antigens: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

MHC class I antigens and immune surveillance in transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

ICAM-1 co-stimulates target cells to facilitate antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7

Prolonged Upregulation of the Expression of HLA Class I Antigens and Co stimulatory Molecules on Melanoma Cells Treated with 5-aza-2??-deoxycytidine (5-AZA-CdR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1365-7